ERIC LARA: Open Payments
NPI 1245944198 · MUNSTER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,550 in 216 payments from 32 companies in 2025. Trend: 2023 $237 · 2024 $3,186 · 2025 $4,550
Food & beverage: $4,550
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $570 |
| Amgen Inc. | 36 | $406 |
| Vanda Pharmaceuticals Inc. | 17 | $369 |
| Novo Nordisk Inc | 11 | $299 |
| Radius Health, Inc. | 11 | $284 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $277 |
| AstraZeneca Pharmaceuticals LP | 7 | $263 |
| Otsuka America Pharmaceutical, Inc. | 11 | $260 |
| Axsome Therapeutics, Inc. | 5 | $182 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $168 |
Products named: FANAPT, OTEZLA, Tymlos, XIFAXAN, REXULTI, Auvelity, UBRELVY, Kerendia.
Industry payments across IN — which companies pay providers there.
